The Lyme Disease Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Lyme Disease Testing Market?
The global market size for Lyme disease testing has seen substantial growth in recent years. The market, standing at $9.77 billion in 2024, is projected to increase to $10.68 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Lyme Disease Testing Industry?
The Lyme Disease Testing Global Market is projected to reach a size of $15.11 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.1%.
Download Your Free Sample of the 2025 Lyme Disease Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Lyme Disease Testing Market?
The key drivers in the lyme disease testing market are:
• Increase in the prevalence of tick-borne diseases
• Heightened demand for treatments for tick-borne illnesses
• Expanded geographic range of ticks due to climate change
• Urgent need for early Lyme disease detection and diagnosis due to rising infection cases.
Global Market Segmentation: Identifying Major Lyme Disease Testing Industry Segments
The lyme disease testing market covered in this report is segmented –
1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples
5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations
Pre-order the 2025 Lyme Disease Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Lyme Disease Testing Market?
The key trends in the lyme disease testing market are:
• The Lyme disease testing market is trending towards the enhancement of diagnostic tools through technological advancements.
• There is a focus on achieving greater test accuracy and reduced turnaround times in Lyme disease diagnosis.
• Early-stage detection of the disease is becoming a major area of emphasis in testing advancements.
• Customization of diagnostic tools according to different laboratory applications is an emerging trend.
Who Are the Top Competitors & Leading Players in the Lyme Disease Testing Market?
Major players in the lyme disease testing market are:
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• Labcorp Holdings Inc.
• Quest Diagnostics Incorporated
• Eurofins Scientific
• BIOMÉRIEUX
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• DiaSorin S.p.A
• Meridian Bioscience
• Everlywell
• Trinity Biotech
• T2 Biosystems
• IGeneX
• Viramed Biotech AG
• Ceres Nanosciences
• Galaxy Diagnostics
• Novatein Biosciences
• Lyme Diagnostics Ltd
Regional Dominance: Which Area Leads the Global Lyme Disease Testing Market?
North America was the largest region in the lyme disease testing market in 2024
